Despite numerous studies indicating inflammatory factors and their resultant products, such as IL-1β, IL-6, IFN-γ, TNF-α and CRP, have been demonstrated to contribute to the pathogenesis of hypertension [29–31], there remains a paucity of research examining the association between these novel systemic inflammatory markers and hypertension. Here, IL1B is linked to hypertensive disorder.